"Designing Growth Strategies is in our DNA"

U.S. Blood Glucose Monitoring System Market Size, Share & Share & COVID-19 Impact Analysis, By Device Type (Continuous Glucose Monitoring System and Self-monitoring Blood Glucose System), By Type (Non-invasive and Invasive), By Modality (Wearable and Non-wearable), By Patient Type (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Institutional Sales and Retail Sales), and Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107369

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 9.6% from 2023 to 2030

Unit

Value (USD billion)

Segmentation

By Device Type, Type, Modality, Patient Type, and Distribution Channel

By Device Type

  • Continuous Glucose Monitoring System
  • Self-monitoring Blood Glucose System

By Type

  • Non-invasive
  • Invasive

By Modality

  • Wearable
  • Non-wearable

By Patient Type

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Institutional Sales
  • Retail Sales
  • 2019-2030
  • 2022
  • 2019-2021
  • 96
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann